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Archives of Psychiatry 
Research, a new name for a 
steadfast focus on psychiatric 
research
Dear colleagues and readers, from its 55th 
volume in 2019, Alcoholism and Psychiatry 
Research, Journal on psychiatric research and 
addictions, will change its name to Archives 
of  Psychiatry Research, An International 
Journal of  Psychiatry and Related Sciences. 
This name change reflects continuous efforts 
by the editorial office to broaden the Jour-
nal’s scope of  interest, as the previous one 
of  addictology significantly encumbered the 
editorial process. This is especially the case in 
the recent years, especially after 2015, with an 
increasing inflow of  new articles, not neces-
sarily falling in the category of  addiction and 
substance dependence. We are aware that this 
is a big change for the Journal, and to a some-
what lesser extent for our scientific commu-
nity. However, due to a growing interest of  
authors willing to publish their research in 
Alcoholism and Psychiatry Research, and en-
thusiastic support by Naklada Slap, we feel 
that it is the right moment for such a shift 
of  focus. That being said, it is our firm be-
lief  that we remain on the right course set by 
Vladimir Hudolin in 1965 when he founded 
Alcoholism, Journal on Alcoholism and Re-
lated Addictions. To support this statement 
we must stress the fact that this Journal has 
been continuously published for well over fif-
ty years, without volumes becoming double 
editions. Furthermore, recently the Journal 
has successfully met the criteria for index-
ation in the Directory of  Open Access Jour-
nals/DOAJ, as well as launched its first ever 
web page at http://apr.kbcsm.hr and set up 
its online manuscript submission system. The 
editorial board has also seen several changes, 
which also reflect the new course set by the 
Editorial Office in order to broaden the po-
tential reader and author base and encompass 
a wider array of  psychiatric topics. After all, it 
is a great pleasure and honour to continue in 
the footsteps of  our predecessors (Vladimir 
Hudolin, Branko Lang, Vladko Thaller and 
Danijel Buljan), albeit that compels us to ad-
here to their high professional criteria.
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Neatly coinciding with the change of  
journal’s name, with this issue we plan to in-
troduce a new section of  this journal. This 
section, titled Back to the Future of  Psychophar-
macology will focus on psychopharmaceutical 
modalities that have undergone the concep-
tualisation phase and are in one of  the phas-
es of  molecule development. This includes 
an additional mechanism of  action in an al-
ready established molecule or combinations 
of  several existing psychopharmacological 
treatment modalities. In a broader sense we 
will address entirely new concepts in psycho-
pharmacology, with emphasis on their poten-
tial clinical applicability. Lately we have been 
witnessing serious struggles in development 
of  new molecules, with increased difficulty 
of  meeting the criteria set by pre-clinical and 
clinical drug studies. Hence, not all molecules 
presented in this section will eventually take 
off  as a clinically used psychopharmaceutical. 
Nevertheless, curiosity and the need to devel-
op new treatment modalities with respect to 
their clinical efficiency and safety, entices us 
to explore psychopharmacological horizons 
while we await new therapeutic possibilities.
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